SNT 0.00% 3.2¢ syntara limited

patch intl - pxs $2-$3 by eoy, page-3

  1. 1,241 Posts.
    PAII is one of the largest shareholders in Pharmaxis Pharmaceuticals Pty,
    an Australian company. PAII has seen this investment grow to a current value
    of approximately $10 million USD on a non-discounted basis. Given the future
    of our investment in Pharmaxis Pharmaceuticals Pty., which trades on the
    Australian Stock Exchange, we believe this investment could grow to
    $20-30 million US by the end of 2005. This will provide a substantial base
    for the company to grow from and potentially increase shareholder value
    dramatically.
    PAII's goal is to increase shareholder value by increasing the net asset
    value of the company to become a mid-range oil and gas company. We are
    attempting to attain this goal through oil and gas production that will
    provide cash flow and to search out new opportunities which will offer
    tremendous "blue sky" to the company and its shareholders.
    If you are not currently on the PAII updates list please send in your
    email to [email protected] or call 1 888 864 7372 with the best way to
    keep you informed. We will send out regular updates and news releases to
    everyone who asks to be on our distribution list.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.000(0.00%)
Mkt cap ! $41.29M
Open High Low Value Volume
3.2¢ 3.2¢ 3.1¢ $37.99K 1.214M

Buyers (Bids)

No. Vol. Price($)
3 1147120 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 289141 4
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.